SCHEMBL8071986

SCHEMBL8071986

Cc1cc(=O)oc2ccc(C(C)(C)C)cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PON1 P27169 1/20 0.63
ALDH1A1 P00352 11/20 0.57
KDM4E B2RXH2 9/20 0.57
HPGD P15428 8/20 0.57
HSD17B10 Q99714 4/20 0.57
MAPT P10636 1/20 0.56
MAOA P21397 1/20 0.51
AKR1B1 P15121 2/20 0.50
MCL1 Q07820 2/20 0.50
STS P08842 1/20 0.50
CYP3A4 P08684 1/20 0.50
THRB P10828 1/20 0.50
CYP1A2 P05177 2/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1B1 Q16678 1/20 0.49
CA9 Q16790 3/20 0.48
GAA P10253 3/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 1/20 0.48
CA5A P35218 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102259 0.86 CA9 (0.62) PON1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8359458 0.81 PON1 (0.61) PON1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL30636721 0.78 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDHSD17B10MAOA
SCHEMBL67818 0.78 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDHSD17B10MAOA
SCHEMBL12181810 0.78 PON1 (0.57) PON1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24865358 0.77 ALDH1A1 (0.72) ALDH1A1KDM4EHPGDHSD17B10AKR1B1
SCHEMBL23056731 0.77 PON1 (0.54) PON1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL27523022 0.77 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDHSD17B10MAOA
SCHEMBL6503693 0.75 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDHSD17B10MAOA
SCHEMBL17861315 0.75 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDHSD17B10MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293715-B2 10a-Azalide compound crosslinked at 10a- and 12-positions TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-10-23 US disclosed
US-20110237784-A1 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-09-29 US disclosed
EP-1036792-A1 Novel fragrance compound QUEST INTERNATIONAL B.V. (NL) 2000-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237784-A1 10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS DCLRE1A, AZI2, CHD9 PON1 2964/4885ALDH1A1 2376/4885KDM4E 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.